Filings

4 documents · 21 matches

1. IMMX Immix Biopharma, Inc. 10-Q 2025-11-07

   Item 4. Controls and Procedures.

   material weakness in our internal control over financial reporting that existed as of December 31, 2024, as discussed in greater
   6 matches in this document Show context Copy citation

2. IMMX Immix Biopharma, Inc. 10-Q 2025-08-08

   Item 4. Controls and Procedures.

   material weakness in our internal control over financial reporting that existed as of December 31, 2024, as discussed in greater
   6 matches in this document Show context Copy citation

3. IMMX Immix Biopharma, Inc. 10-Q 2025-05-08

   Item 4. Controls and Procedures.

   material weakness in our internal control over financial reporting that existed as of December 31, 2024, as discussed in greater
   6 matches in this document Show context Copy citation

4. IMMX Immix Biopharma, Inc. 10-K 2026-03-25

   Item 9A. Controls and Procedures

   material weakness described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2024, related
   3 matches in this document Show context Copy citation